# US 2024/0200132 A1 · Method for preparation and high- throughput microbial single-cell rna sequencing of bacteria

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0200132 A1
- Document ID: US20240200132A1
- Status: Published application
- Kind: A1
- Application number: 18/415,802
- Filed: 2024-01-18
- Published: 2024-06-20
- Earliest claimed: 2019-11-27
- Assignees: University of Washington
- Applicants: University Of Washington
- Inventors: Georg Seelig; Anna Kuchina; Leandra Brettner; William DePaolo
- Web page: https://patentgrep.com/patent/US20240200132A1

## CPC

- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Methods and kits for uniquely labeling nucleic acid molecules within a plurality of microbial cells are described. In an embodiment, the method comprises fixing and permeabilizing the plurality of microbial cells; dissociating microbial cell aggregates within a suspension comprising the plurality of microbial cells; reverse transcribing mRNA within the plurality of microbial cells to provide cDNA; and combinatorially labelling the cDNA to provide labelled cDNA.

## Claims

### Claim 1

A method of labeling RNA molecules with cell-specific tags, the method comprising:
a) providing a suspension comprising a plurality of fixed and permeabilized microbial cells, wherein each of the plurality of fixed, permeabilized cells comprises RNA;
b) dissociating microbial cell aggregates within the suspension;
c) distributing the plurality of microbial cells in the suspension into a first plurality of aliquots, wherein each of the first plurality of aliquots comprises more than one microbial cell;
d) reverse transcribing RNA molecules within the microbial cells in the first plurality of aliquots to generate complementary DNA (cDNA) molecules, wherein the RNA molecules are reverse transcribed using reverse transcription (RT) primers each comprising:
i) an RT barcode sequence, wherein multiple distinct RT primer barcode sequences are present among the RT primers used in the first plurality of aliquots, and wherein the RT primer barcode sequences present in each individual aliquot of the first plurality of aliquots are specific to the individual aliquot; and
ii) a 5′ overhang sequence located 5′ of the RT barcode sequence;
e) combining the microbial cells from the first plurality of aliquots;
f) distributing the combined microbial cells from the first plurality of aliquots into a second plurality of aliquots, wherein each of the second plurality of aliquots comprises more than one microbial cell; and
g) coupling nucleic acid tags to the cDNA molecules within the microbial cells of the second plurality of aliquots, thereby generating tagged cDNA molecules, wherein each of the nucleic acid tags comprises:
i) a tag barcode sequence, wherein multiple distinct tag barcode sequences are present among the nucleic acid tags used in the second plurality of aliquots, and wherein the tag barcode sequences present in each individual aliquot of the second plurality of aliquots are specific to the individual aliquot; and
ii) a 3′ hybridization sequence located 3′ of the tag barcode sequence and/or a 5′ hybridization sequence located 5′ of the tag barcode sequence.

### Claim 2 (depends on 1)

The method of claim 1, wherein the 3′ hybridization sequence of the nucleic acid tags is complementary to the 5′ overhang sequence of the RT primers.

### Claim 3 (depends on 1)

The method of claim 1, wherein the fixed and permeabilized microbial cells were fixed using formaldehyde.

### Claim 4 (depends on 1)

The method of claim 1, wherein the fixed and permeabilized microbial cells were permeabilized using a detergent and/or a cell-wall degradation enzyme.

### Claim 5 (depends on 4)

The method of claim 4, wherein the detergent comprises Tween 20 and/or Triton X-100.

### Claim 6 (depends on 4)

The method of claim 4, wherein the cell-wall degradation enzyme is a lysozyme.

### Claim 7 (depends on 6)

The method of claim 6, wherein the lysozyme comprises the amino acid sequence of SEQ ID NO: 1.

### Claim 8 (depends on 6)

The method of claim 6, wherein the permeabilization of the microbial cells comprised incubating the cells in the presence of 2.5 mg/ml lysozyme at 37° C. for 15 minutes.

### Claim 9 (depends on 1)

The method of claim 1, wherein dissociating microbial cell aggregates within the suspension comprises agitating the suspension.

### Claim 10 (depends on 9)

The method of claim 9, wherein agitating the suspension comprises vortexing the suspension.

### Claim 11 (depends on 9)

The method of claim 9, wherein dissociating microbial cell aggregates within the suspension comprises filtering the suspension.

### Claim 12 (depends on 9)

The method of claim 9, wherein dissociating microbial cell aggregates within the suspension comprises vortexing the suspension for 1 minute, and filtering the vortexed suspension using a cell strainer.

### Claim 13 (depends on 9)

The method of claim 9, wherein dissociating microbial cell aggregates within the suspension comprises: i) vortexing the suspension for 1 minute, ii) filtering the vortexed suspension using a 10 um cell strainer, iii) re-filtering the vortexed suspension using a 1 um cell strainer, and iv) vortexing the re-filtered suspension for 1 minute.

### Claim 14 (depends on 1)

The method of claim 1, further comprising enriching mRNA within the plurality of microbial cells by polyadenylating the mRNA, wherein the mRNA is polyadenylated prior to step (b).

### Claim 15 (depends on 14)

The method of claim 14, wherein the mRNA is polyadenylated using E. coli Poly(A) polymerase (PAP1).

### Claim 16 (depends on 15)

The method of claim 15, wherein the PAP1 comprises the amino acid sequence of SEQ ID NO: 2.

### Claim 17 (depends on 1)

The method of claim 1, wherein each of the RT primers comprises a poly(dT) sequence or a random sequence.

### Claim 18 (depends on 17)

The method of claim 17, wherein the poly(dT) sequence is an anchored poly(dT)15 sequence, and/or the random sequence is a random hexamer.

### Claim 19 (depends on 1)

The method of claim 1, further comprising an additional aggregate dissociation step performed subsequent to step (d) and prior to step (g), the additional step comprising: i) vortexing the plurality of microbial cells, ii) filtering the vortexed plurality of microbial cells using a cell strainer, and iii) sonicating or vortexing the filtered plurality of microbial cells.

### Claim 20 (depends on 1)

The method of claim 1, wherein steps (e) through (g) are repeated one or more times, thereby generating repeatedly tagged cDNA molecules.

### Claim 21 (depends on 20)

The method of claim 20, wherein steps (e) through (g) are repeated a number of times sufficient to generate at least as many distinct combinations of barcode sequences among the repeatedly tagged cDNA molecules as the number of microbial cells in the plurality of microbial cells.

### Claim 22 (depends on 20)

The method of claim 20, wherein the nucleic acid tags that are coupled to the tagged or repeatedly tagged cDNA molecules during the last of the one or more times that steps (c) to (e) are repeated comprise biotin.

### Claim 23 (depends on 1)

The method of claim 1, wherein the coupling in step (g) comprises ligating a 3′ end of a nucleic acid tag to the 5′ end of a cDNA molecule.

### Claim 24 (depends on 1)

The method of claim 1, further comprising:
(h) combining the microbial cells from the second plurality of aliquots;
(i) dividing the combined microbial cells from the second plurality of aliquots into a plurality of samples, wherein each sample of the plurality of samples comprises more than one microbial cell;
(j) lysing the microbial cells in each of the plurality of samples, thereby releasing the tagged cDNA molecules and forming a lysate in each sample of the plurality of samples; and
(k) isolating the released tagged cDNA molecules from the lysate in one or more of the plurality of samples.

### Claim 25 (depends on 24)

The method of claim 24, wherein the released tagged cDNA molecules are isolated from the lysate using a binding agent, such that the isolated tagged cDNA molecules are bound to the binding agent.

### Claim 26 (depends on 25)

The method of claim 25, further comprising:
(l) conducting a template switch of the released tagged cDNA molecules bound to the binding agent.

### Claim 27 (depends on 26)

The method of claim 26, further comprising:
(m) amplifying the released tagged cDNA molecules using amplification primers,
wherein at least a portion of the amplification primers used in each of the plurality of samples comprise an index sequence,
wherein multiple distinct index sequences are present among the amplification primers used in the plurality of samples, and
wherein the index sequences present in each individual sample of the plurality of samples are specific to the individual sample.

### Claim 28 (depends on 27)

The method of claim 27, wherein the tagged cDNA molecules amplified in step (m) are present in an amplified cDNA solution, and further comprising:
(n) size selecting the tagged cDNA molecules amplified in step (m) by introducing a solid phase reversible immobilization (SPRI) bead solution to the amplified cDNA solution.

### Claim 29 (depends on 27)

The method of claim 27, further comprising:
(o) sequencing the tagged cDNA molecules amplified in step (m).

### Claim 30 (depends on 29)

The method of claim 29, wherein the cDNA molecules have been amplified using one or more amplification primers comprising an index sequence, and wherein the method further comprises:
(p) grouping the sequencing reads obtained in step (o) by any combination of two or more sequences selected from the group consisting of RT primer barcode sequence, tag barcode sequence, and index sequence.

### Claim 31 (depends on 30)

The method of claim 30, wherein steps (e) to (g) have been repeated one or more times, thereby producing repeatedly tagged cDNA molecules each comprising multiple tag barcode sequences, and wherein the sequencing reads are grouped by any combination of two or more sequences selected from the group consisting of RT primer sequence, any one or more of the multiple tag barcode sequences, and index sequence.

### Claim 32 (depends on 1)

The method of claim 1, wherein the first plurality of aliquots are distributed in a multi-well plate, and wherein each of the multiple distinct barcode sequences is present in only one well of the multi-well plate.

### Claim 33 (depends on 1)

The method of claim 1, wherein the second plurality of aliquots are distributed in a multi-well plate, and wherein each of the multiple distinct tag barcode sequences is present in only one well of the multi-well plate.
